Arca Biopharma | ABIO - Creditori Commerciali

Prezzo Delle Azioni
41.56
Cambio Giornaliero
2.65 6.81%
Mensile
16.87%
Annuale
236.25%
Q1 Previsione
37.74




Creditori Commerciali Cambiamento Data
Alterity Therapeutics Limited AUD 1.27M 1.81M 2024-12
Amgen USD 20.89B 1.25B 2025-12
Arca Biopharma USD 4.16M 1.95M 2025-12
Biogen USD 432M 18.9M 2025-12
Brainstorm Cell Therapeutics USD 6.42M 423K 2025-09
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Capricor Therapeutics 1.65M 1.06M 2025-12
Cipla INR 30.35B 1.98B 2025-09
Clal Biotechnology ILS 21.05M 1.62M 2021-12
Compugen USD 2.35M 6.77M 2025-12
CSL USD 3.17B 290M 2025-12
Cytokinetics USD 105.62M 83.53M 2025-12
Daiichi Sankyo JPY 568.5B 16.84B 2025-12
Gilead Sciences USD 808M 226M 2025-09
GlaxoSmithKline GBP 15.38B 294M 2025-12
Grifols EUR 987.75M 47.87M 2025-12
Laboratory Of America USD 840.8M 172.3M 2025-12
Myriad Genetics USD 30M 1.8M 2025-12
Otsuka Holdings JPY 225.56B 31.54B 2025-12
Pfizer USD 5.02B 142M 2025-09
United Therapeutics USD 7.1M 460.9M 2025-12